X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with J.B.Chemicals - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs J.B.CHEMICALS - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER J.B.CHEMICALS PFIZER/
J.B.CHEMICALS
 
P/E (TTM) x 31.1 15.0 208.2% View Chart
P/BV x 5.0 2.4 209.3% View Chart
Dividend Yield % 0.7 0.2 399.3%  

Financials

 PFIZER   J.B.CHEMICALS
EQUITY SHARE DATA
    PFIZER
Mar-16
J.B.CHEMICALS
Mar-16
PFIZER/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs2,724318 856.3%   
Low Rs1,611200 807.5%   
Sales per share (Unadj.) Rs440.9148.0 297.9%  
Earnings per share (Unadj.) Rs48.719.1 255.2%  
Cash flow per share (Unadj.) Rs75.823.9 316.4%  
Dividends per share (Unadj.) Rs15.000.50 3,000.0%  
Dividend yield (eoy) %0.70.2 358.2%  
Book value per share (Unadj.) Rs462.9128.9 359.0%  
Shares outstanding (eoy) m45.7584.82 53.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.91.7 281.1%   
Avg P/E ratio x44.513.6 328.2%  
P/CF ratio (eoy) x28.610.8 264.7%  
Price / Book Value ratio x4.72.0 233.3%  
Dividend payout %30.82.6 1,175.7%   
Avg Mkt Cap Rs m99,16321,951 451.7%   
No. of employees `0002.92.7 105.7%   
Total wages/salary Rs m2,7581,841 149.8%   
Avg. sales/employee Rs Th6,981.74,590.9 152.1%   
Avg. wages/employee Rs Th954.5673.4 141.7%   
Avg. net profit/employee Rs Th771.1592.1 130.2%   
INCOME DATA
Net Sales Rs m20,17012,551 160.7%  
Other income Rs m857542 158.3%   
Total revenues Rs m21,02813,093 160.6%   
Gross profit Rs m4,3102,055 209.8%  
Depreciation Rs m1,239412 300.4%   
Interest Rs m596 5.4%   
Profit before tax Rs m3,9232,088 187.9%   
Minority Interest Rs m00 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m990-   
Tax Rs m1,794469 382.5%   
Profit after tax Rs m2,2281,619 137.6%  
Gross profit margin %21.416.4 130.5%  
Effective tax rate %45.722.5 203.6%   
Net profit margin %11.012.9 85.6%  
BALANCE SHEET DATA
Current assets Rs m16,2997,778 209.6%   
Current liabilities Rs m7,5944,358 174.2%   
Net working cap to sales %43.227.2 158.4%  
Current ratio x2.11.8 120.3%  
Inventory Days Days6555 119.4%  
Debtors Days Days2680 32.2%  
Net fixed assets Rs m8,6225,713 150.9%   
Share capital Rs m458170 269.8%   
"Free" reserves Rs m20,72210,547 196.5%   
Net worth Rs m21,18010,937 193.6%   
Long term debt Rs m250-   
Total assets Rs m29,13715,574 187.1%  
Interest coverage x755.522.8 3,310.6%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70.8 85.9%   
Return on assets %7.711.0 69.6%  
Return on equity %10.514.8 71.1%  
Return on capital %19.020.0 95.1%  
Exports to sales %0.148.7 0.1%   
Imports to sales %17.57.1 246.9%   
Exports (fob) Rs m126,115 0.2%   
Imports (cif) Rs m3,526889 396.7%   
Fx inflow Rs m526,169 0.8%   
Fx outflow Rs m1401,285 10.9%   
Net fx Rs m-884,884 -1.8%   
CASH FLOW
From Operations Rs m3,4361,397 246.0%  
From Investments Rs m-6,991-320 2,182.6%  
From Financial Activity Rs m-619-1,196 51.7%  
Net Cashflow Rs m-4,174-102 4,079.7%  

Share Holding

Indian Promoters % 0.0 55.4 -  
Foreign collaborators % 63.9 0.3 21,300.0%  
Indian inst/Mut Fund % 7.5 3.4 221.2%  
FIIs % 4.9 3.9 125.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 37.0 64.1%  
Shareholders   85,207 30,437 279.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   ALKEM LABORATORIES  PLETHICO PHARMA  GLENMARK PHARMA  TORRENT PHARMA  FRESENIUS KABI ONCO.  

Compare PFIZER With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes Marginally Lower; Capital Goods & Realty Stocks Fall(Closing)

Indian share markets witnessed selling pressure in the final hour of trade to finish just below the dotted line. At the closing bell, the BSE Sensex closed lower by 71 points.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Feb 20, 2018 03:35 PM

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS